Abbott Laboratories (XSWX:ABT) GF Value Rank: 8 (As of Jul. 07, 2026) — 33% Above Median


XSWX:ABT Abbott Laboratories XSWX:ABT
76 GF Score
Price CHF76.00
GF Value CHF103.46
View Full Analysis

What is Abbott Laboratories GF Value Rank?

Abbott Laboratories XSWX:ABT 76 GF Value Rank is 8 as of Jul. 07, 2026, which is 33% above its 10-year median of 6.00. GuruFocus rates XSWX:ABT with a GF Score™ of 76/100 and a GF Value™ of CHF103.46.

Abbott Laboratories has the GF Value Rank of 8.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Abbott Laboratories GF Value Rank Related Terms

XSWX:ABT vs SYK, MDT, BSX: GF Value Rank Comparison

For the Medical Devices subindustry, Abbott Laboratories's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories GF Value Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's GF Value Rank falls into.


XSWX:ABT
76GF Score
Abbott Laboratories XSWX:ABT
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 8 mean?
Abbott Laboratories (XSWX:ABT) has a GF Value Rank of 8 as of Jul. 07, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Abbott Laboratories and its competitors. This is 33% above median its historical median of 6.00. Over the past decade, Abbott Laboratories' GF Value Rank has ranged from 1.00 to 10.00.
Is Abbott Laboratories' GF Value Rank too high?
Abbott Laboratories' current GF Value Rank of 8 is 33% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Abbott Laboratories has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' GF Value Rank compare to SYK and MDT?
Abbott Laboratories' GF Value Rank of 8 can be compared against companies in the Medical Devices & Instruments industry. Historically, Abbott Laboratories' own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Medical Devices & Instruments company?
A good GF Value Rank depends on the Medical Devices & Instruments industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current GF Value Rank is 8, which is 33% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current GF Value Rank of 8. The stock's GF Value™ is CHF103.46, compared to a current price of CHF76.00 — trading 26.5% below its estimated fair value. The current GF Value Rank is 8, which is 33% above median its 10-year median of 6.00. Abbott Laboratories' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current GF Value Rank is 8 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF76.00 is trading 26.5% below its estimated GF Value™ of CHF103.46.

Key valuation signals for XSWX:ABT:

  • GF Value Rank: 8 (33% above median its 10-year median of 6.00)
  • GF Value™: CHF103.46 vs. price of CHF76.00 (26.5% below fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
76GF Score

Get the complete analysis for XSWX:ABT

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF76.00
Price
CHF103.46
GF Value